A detailed history of Schroder Investment Management Group transactions in Chroma Dex Corp. stock. As of the latest transaction made, Schroder Investment Management Group holds 10,883 shares of CDXC stock, worth $66,821. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,883
Previous 10,793 0.83%
Holding current value
$66,821
Previous $74,000 10.81%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 13, 2025

BUY
$5.42 - $7.08 $487 - $637
90 Added 0.83%
10,883 $66,000
Q1 2025

May 13, 2025

BUY
$5.26 - $8.55 $56,771 - $92,280
10,793 New
10,793 $74,000

Others Institutions Holding CDXC

About ChromaDex Corp.


  • Ticker CDXC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,350,896
  • Market Cap $420M
  • Description
  • ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...
More about CDXC
Track This Portfolio

Track Schroder Investment Management Group Portfolio

Follow Schroder Investment Management Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schroder Investment Management Group, based on Form 13F filings with the SEC.

News

Stay updated on Schroder Investment Management Group with notifications on news.